Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-methylpropyl)phenyl]butyl]benzene

1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-methylpropyl)phenyl]butyl]benzene is listed in the pharmaceutical impurity collection. Its represented structure has formula C24H34 and a calculated molecular weight of 322.54 g/mol.

2D chemical structure

Chemical identity

Catalog name
1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-methylpropyl)phenyl]butyl]benzene
Common name
Not available
Chemical name
1-(2-methylpropyl)-4-[4-[4-(2-methylpropyl)phenyl]butan-2-yl]benzene
CAS
Not available
SMILES
CC(C)Cc1ccc(CCC(C)c2ccc(CC(C)C)cc2)cc1
InChI
InChI=1S/C24H34/c1-18(2)16-22-10-8-21(9-11-22)7-6-20(5)24-14-12-23(13-15-24)17-19(3)4/h8-15,18-20H,6-7,16-17H2,1-5H3
InChIKey
OUZGXARWSGTBAD-UHFFFAOYSA-N
Associated API
Matrix - API Family Ibuprofen

Record ID: A54e77fc7ca02

Computed properties

C24H34 Molecular formula
322.536 g/molMolecular weight
322.2661 DaMonoisotopic exact mass
0 ŲTopological polar surface area
6.8199 Calculated LogP (Wildman–Crippen)
106.704 cm³/molMolar refractivity (Wildman–Crippen)
0 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H 0 8 16 24 32 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight322.53650.89
Calculated LogP (Wildman–Crippen)6.819996.87
Topological polar surface area00.50
Hydrogen-bond acceptors00.47
Hydrogen-bond donors011.28
Rotatable bonds (strict)882.26

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC24H34dimensionless
Molecular weight322.536g/mol
Monoisotopic exact mass322.2661Da
Topological polar surface area0Ų
Calculated LogP (Wildman–Crippen)6.8199dimensionless
Molar refractivity (Wildman–Crippen)106.704cm³/mol
Hydrogen-bond acceptors0count
Hydrogen-bond donors0count
Rotatable bonds (strict)8count
Heavy atoms24count
Heteroatoms0count
Rings2count
Aromatic rings2count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.5fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area148.8678Ų
Valence electrons130count
Radical electrons0count
Bertz complexity586.9404index
Balaban J1.8659index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-methylpropyl)phenyl]butyl]benzene

Qualification and safety assessment of 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-methylpropyl)phenyl]butyl]benzene

Explore toxicological qualification of 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-methylpropyl)phenyl]butyl]benzene and ICH M7 mutagenic impurity assessment of 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-methylpropyl)phenyl]butyl]benzene for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-methylpropyl)phenyl]butyl]benzene and acceptable intake and limit justification for 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-methylpropyl)phenyl]butyl]benzene. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 1-(2-Methylpropyl)-4-[(3RS)-3-[4-(2-methylpropyl)phenyl]butyl]benzene

Explore Altox services and software through the Altox Pharma-Hub.